{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:21:12Z","timestamp":1790803272620,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ejphar.2024.177011","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T08:53:07Z","timestamp":1726649587000},"page":"177011","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Topical histone deacetylase inhibitor remetinostat improves IMQ-induced psoriatic dermatitis via suppressing dendritic cell maturation and keratinocyte differentiation and inflammation"],"prefix":"10.1016","volume":"983","author":[{"given":"Liping","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huining","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingchen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2024.177011_bib1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1155\/MI.2005.273","article-title":"Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity","volume":"2005","author":"Arican","year":"2005","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.ejphar.2024.177011_bib2","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2024.177011_bib3","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.jaad.2020.01.036","article-title":"Cannabinoids for the treatment of chronic pruritus: a review","volume":"82","author":"Avila","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejphar.2024.177011_bib4","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/1523-1747.ep12462014","article-title":"Abnormal sequence of expression of differentiation markers in psoriatic epidermis: inversion of two steps in the differentiation program?","volume":"90","author":"Bernard","year":"1988","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejphar.2024.177011_bib5","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ni0407-345","article-title":"T(H)-17 cells in the circle of immunity and autoimmunity","volume":"8","author":"Bettelli","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ejphar.2024.177011_bib6","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.semcancer.2020.11.005","article-title":"Anticancer properties of chimeric HDAC and kinase inhibitors","volume":"83","author":"Biersack","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ejphar.2024.177011_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18122514","article-title":"Models in the research process of psoriasis","volume":"18","author":"Boche\u0144ska","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.177011_bib8","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ejphar.2024.177011_bib9","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1189\/jlb.0708401","article-title":"Blocking TH17-polarizing cytokines by histone deacetylase inhibitors in vitro and in vivo","volume":"84","author":"Bosisio","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.ejphar.2024.177011_bib10","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nchembio.313","article-title":"Chemical phylogenetics of histone deacetylases","volume":"6","author":"Bradner","year":"2010","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejphar.2024.177011_bib11","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/1744666X.2018.1454835","article-title":"New therapies versus first-generation biologic drugs in psoriasis: a review of adverse events and their management","volume":"14","author":"Carrascosa","year":"2018","journal-title":"Expet Rev. Clin. Immunol."},{"key":"10.1016\/j.ejphar.2024.177011_bib12","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1002\/eji.201344150","article-title":"Dendritic cell development requires histone deacetylase activity","volume":"44","author":"Chauvistr\u00e9","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ejphar.2024.177011_bib13","doi-asserted-by":"crossref","first-page":"754","DOI":"10.7150\/thno.51154","article-title":"Metabolomic profiling reveals amino acid and carnitine alterations as metabolic signatures in psoriasis","volume":"11","author":"Chen","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.ejphar.2024.177011_bib14","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/17460441.2018.1463214","article-title":"Murine models of psoriasis and their usefulness for drug discovery","volume":"13","author":"Chuang","year":"2018","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejphar.2024.177011_bib15","doi-asserted-by":"crossref","DOI":"10.1111\/dth.12503","article-title":"Management of long-term therapy with biological drugs in psoriatic patients with latent tuberculosis infection in real life setting","volume":"30","author":"Conti","year":"2017","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.ejphar.2024.177011_bib16","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/jid.2009.59","article-title":"The IL-23\/Th17 axis in the immunopathogenesis of psoriasis","volume":"129","author":"Di Cesare","year":"2009","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejphar.2024.177011_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22179294","article-title":"The role of epigenetic factors in psoriasis","volume":"22","author":"Dopytalska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.177011_bib18","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1016\/S0190-9622(98)70309-3","article-title":"The pathogenesis of psoriasis and the mechanism of action of tazarotene","volume":"39","author":"Duvic","year":"1998","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejphar.2024.177011_bib19","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/bjd.14021","article-title":"Lack of preclinical support for the efficacy of histone deacetylase inhibitors in the treatment of psoriasis","volume":"174","author":"Ekman","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejphar.2024.177011_bib20","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.exphem.2012.06.008","article-title":"Impact of HDAC inhibitors on dendritic cell functions","volume":"40","author":"Frikeche","year":"2012","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.ejphar.2024.177011_bib21","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.imbio.2011.11.010","article-title":"Impact of valproic acid on dendritic cells function","volume":"217","author":"Frikeche","year":"2012","journal-title":"Immunobiology"},{"key":"10.1016\/j.ejphar.2024.177011_bib22","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s40265-015-0388-8","article-title":"Panobinostat: first global approval","volume":"75","author":"Garnock-Jones","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2024.177011_bib23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.expneurol.2012.12.006","article-title":"Vorinostat, a histone deacetylase inhibitor, suppresses dendritic cell function and ameliorates experimental autoimmune encephalomyelitis","volume":"241","author":"Ge","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2024.177011_bib24","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1365-2133.2012.11099.x","article-title":"Psoriasis: rationale for targeting interleukin-17","volume":"167","author":"Girolomoni","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejphar.2024.177011_bib25","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41392-023-01655-6","article-title":"Signaling pathways and targeted therapies for psoriasis","volume":"8","author":"Guo","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejphar.2024.177011_bib26","article-title":"NHWD-1062 ameliorates inflammation and proliferation by the RIPK1\/NF-\u03baB\/TLR1 axis in Psoriatic Keratinocytes","volume":"162","author":"Guo","year":"2023","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"key":"10.1016\/j.ejphar.2024.177011_bib27","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1111\/bph.15652","article-title":"Repurposing the anthelmintic praziquantel to treat psoriasis","volume":"178","author":"Hao","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.177011_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/life10090157","article-title":"Histone deacetylase 1 and sirtuin 1 expression in psoriatic skin: a comparison between guttate and plaque psoriasis","volume":"10","author":"Hwang","year":"2020","journal-title":"Life"},{"key":"10.1016\/j.ejphar.2024.177011_bib29","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/1523-1747.ep12665870","article-title":"Differences in involucrin immunolabeling within cornified cell envelopes in normal and psoriatic epidermis","volume":"104","author":"Ishida-Yamamoto","year":"1995","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejphar.2024.177011_bib30","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jdermsci.2023.05.001","article-title":"Topical histone deacetylase 1 inhibitor Entinostat ameliorates psoriasiform dermatitis through suppression of IL-17A response","volume":"110","author":"Jiang","year":"2023","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.ejphar.2024.177011_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176382","article-title":"A BET inhibitor, NHWD-870, can downregulate dendritic cells maturation via the IRF7-mediated signaling pathway to ameliorate imiquimod-induced psoriasis-like murine skin inflammation","author":"Jin","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.177011_bib32","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1177\/039463200902200227","article-title":"Apicidin, the histone deacetylase inhibitor, suppresses Th1 polarization of murine bone marrow-derived dendritic cells","volume":"22","author":"Jung","year":"2009","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.177011_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.941071","article-title":"Dendritic cells and macrophages in the pathogenesis of psoriasis","volume":"13","author":"Kamata","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2024.177011_bib34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1001\/jamadermatol.2021.4549","article-title":"Treatment of cutaneous squamous cell carcinoma with the topical histone deacetylase inhibitor remetinostat","volume":"158","author":"Kilgour","year":"2022","journal-title":"JAMA dermatology"},{"key":"10.1016\/j.ejphar.2024.177011_bib35","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1158\/1078-0432.CCR-21-0560","article-title":"Phase II open-label, single-arm trial to investigate the efficacy and safety of topical remetinostat gel in patients with basal cell carcinoma","volume":"27","author":"Kilgour","year":"2021","journal-title":"Clin. Cancer Res. : an official journal of the American Association for Cancer Research"},{"key":"10.1016\/j.ejphar.2024.177011_bib36","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/jlcr.4026","article-title":"Nitrilase mediated mild hydrolysis of a carbon-14 nitrile for the radiosynthesis of 4-(7-hydroxycarbamoyl-[1-(14) C-heptanoyl]-oxy)-benzoic acid methyl ester, [(14) C]-SHP-141: a novel class I\/II histone deacetylase (HDAC) inhibitor","volume":"66","author":"Kitson","year":"2023","journal-title":"J. Label. Compd. Radiopharm."},{"key":"10.1016\/j.ejphar.2024.177011_bib37","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1189\/jlb.1204697","article-title":"Myeloperoxidase: friend and foe","volume":"77","author":"Klebanoff","year":"2005","journal-title":"J. Leukoc. Biol."},{"issue":"Suppl. 2","key":"10.1016\/j.ejphar.2024.177011_bib38","first-page":"ii30","article-title":"Psoriasis pathophysiology: current concepts of pathogenesis","volume":"64","author":"Krueger","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejphar.2024.177011_bib39","article-title":"Challenges and future trends in the treatment of psoriasis","volume":"24","author":"Lee","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.177011_bib40","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.7150\/thno.52891","article-title":"Polysaccharide mycophenolate-based nanoparticles for enhanced immunosuppression and treatment of immune-mediated inflammatory diseases","volume":"11","author":"Li","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.ejphar.2024.177011_bib41","article-title":"Using imiquimod-induced psoriasis-like skin as a model to measure the skin penetration of anti-psoriatic drugs","volume":"10","author":"Lin","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2024.177011_bib42","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ejphar.2024.177011_bib43","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/sj.onc.1210204","article-title":"Discovery and development of SAHA as an anticancer agent","volume":"26","author":"Marks","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2024.177011_bib44","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s12016-012-8306-2","article-title":"Cytokine-based therapy in psoriasis","volume":"44","author":"Mitra","year":"2013","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.ejphar.2024.177011_bib45","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1080\/10408363.2023.2177251","article-title":"Histone deacetylase inhibitors as a potential new treatment for psoriatic disease and other inflammatory conditions","volume":"60","author":"Nazri","year":"2023","journal-title":"Crit. Rev. Clin. Lab Sci."},{"key":"10.1016\/j.ejphar.2024.177011_bib46","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nri2622","article-title":"Skin immune sentinels in health and disease","volume":"9","author":"Nestle","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejphar.2024.177011_bib47","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s40265-014-0275-8","article-title":"Belinostat: first global approval","volume":"74","author":"Poole","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2024.177011_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105678","article-title":"Triptolide analog LLDT-8 ameliorates psoriasis-like dermatitis in BALB\/c mice via suppressing the IL-36\u03b1 signaling pathway","volume":"169","author":"Qi","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2024.177011_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061475","article-title":"Psoriasis pathogenesis and treatment","volume":"20","author":"Rendon","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.177011_bib50","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/exd.14502","article-title":"Vorinostat, a histone deacetylase inhibitor, as a potential novel treatment for psoriasis","volume":"31","author":"Samuelov","year":"2022","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.ejphar.2024.177011_bib51","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jdermsci.2012.09.001","article-title":"Histone deacetylases inhibitor Trichostatin A ameliorates DNFB-induced allergic contact dermatitis and reduces epidermal Langerhans cells in mice","volume":"68","author":"Shi","year":"2012","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.ejphar.2024.177011_bib52","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/s41419-021-04284-5","article-title":"Inhibition of keratinocyte ferroptosis suppresses psoriatic inflammation","volume":"12","author":"Shou","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2024.177011_bib53","first-page":"859","article-title":"The discovery and development of romidepsin for the treatment of T-cell lymphoma","volume":"12","author":"Smolewski","year":"2017","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejphar.2024.177011_bib54","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13073-017-0415-3","article-title":"Imiquimod has strain-dependent effects in mice and does not uniquely model human psoriasis","volume":"9","author":"Swindell","year":"2017","journal-title":"Genome Med."},{"key":"10.1016\/j.ejphar.2024.177011_bib55","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/s10637-018-0696-4","article-title":"A phase 1 trial of Vorinostat in combination with concurrent chemoradiation therapy in the treatment of advanced staged head and neck squamous cell carcinoma","volume":"37","author":"Teknos","year":"2019","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.ejphar.2024.177011_bib56","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41419-019-2212-y","article-title":"Piperlongumine regulates epigenetic modulation and alleviates psoriasis-like skin inflammation via inhibition of hyperproliferation and inflammation","volume":"11","author":"Thatikonda","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2024.177011_bib57","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"van der Fits","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2024.177011_bib58","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.cellimm.2008.04.016","article-title":"Butyrate inhibits functional differentiation of human monocyte-derived dendritic cells","volume":"253","author":"Wang","year":"2008","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.ejphar.2024.177011_bib59","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1172\/JCI97426","article-title":"MicroRNA-210 overexpression promotes psoriasis-like inflammation by inducing Th1 and Th17 cell differentiation","volume":"128","author":"Wu","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2024.177011_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106318","article-title":"Topical VX-509 attenuates psoriatic inflammation through the STAT3\/FABP5 pathway in keratinocytes","volume":"182","author":"Yan","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2024.177011_bib61","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/j.jid.2022.01.002","article-title":"Lidocaine ameliorates psoriasis by obstructing pathogenic CGRP signaling\u2012mediated sensory neuron\u2012dendritic cell communication","volume":"142","author":"Yin","year":"2022","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejphar.2024.177011_bib62","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1007\/s11033-021-07065-7","article-title":"Trichostatin A inhibits dendritic cell maturation through down-regulating NF-\u03ba B (p65) pathway","volume":"49","author":"Yu","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.ejphar.2024.177011_bib63","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.7150\/ijbs.41940","article-title":"Ozone therapy attenuates NF-\u03baB-Mediated local inflammatory response and activation of Th17 cells in treatment for psoriasis","volume":"16","author":"Zeng","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ejphar.2024.177011_bib64","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41392-022-01219-0","article-title":"Intestinal dysbiosis exacerbates the pathogenesis of psoriasis-like phenotype through changes in fatty acid metabolism","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct. Targeted Ther."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924007015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924007015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T04:52:14Z","timestamp":1730436734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299924007015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":64,"alternative-id":["S0014299924007015"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.177011","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical histone deacetylase inhibitor remetinostat improves IMQ-induced psoriatic dermatitis via suppressing dendritic cell maturation and keratinocyte differentiation and inflammation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.177011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"177011"}}